Evaluation of the Use of Dual Antiplatelet Therapy beyond the First Year after Acute Coronary Syndrome

Clinical practice guidelines recommend extending dual antiplatelet therapy (DAPT) beyond 1 year after acute coronary syndrome (ACS) in patients with high ischemic risk and without high bleeding risk. The aim of this study was to identify variables associated with DAPT prolongation in a cohort of 196...

Descripción completa

Detalles Bibliográficos
Autores principales: Bonanad, Clara, Raposeiras-Roubin, Sergio, García-Blas, Sergio, Núñez-Gil, Iván, Vergara-Uzcategui, Carlos, Díez-Villanueva, Pablo, Bañeras, Jordi, Badía Molins, Clara, Aboal, Jaime, Carreras, Jose, Bodi, Vicente, Gabaldón-Pérez, Ana, Mateus-Porta, Gemma, Parada Barcia, Jose Antonio, Martínez-Sellés, Manuel, Chorro, Francisco Javier, Ariza-Solé, Albert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8955645/
https://www.ncbi.nlm.nih.gov/pubmed/35330004
http://dx.doi.org/10.3390/jcm11061680

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8955645/
https://www.ncbi.nlm.nih.gov/pubmed/35330004
http://dx.doi.org/10.3390/jcm11061680

Ejemplares similares